Literature DB >> 33436398

Changes in Cardiovascular Biomarkers Associated With the Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Ertugliflozin in Patients With Chronic Kidney Disease and Type 2 Diabetes.

Patrick R Lawler1,2,3, Hongyan Liu4,5, Claudia Frankfurter6, Leif Erik Lovblom7, Yuliya Lytvyn8,6, Dylan Burger9, Kevin D Burns9, Davor Brinc10,11, David Z I Cherney8,5,12.   

Abstract

Entities:  

Year:  2021        PMID： 33436398     DOI： 10.2337/dc20-2265

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  6 in total

Review 1.  SGLT2 Inhibition in Type 1 Diabetes with Diabetic Kidney Disease: Potential Cardiorenal Benefits Can Outweigh Preventable Risk of Diabetic Ketoacidosis.

Authors:  Hongyan Liu; Vikas S Sridhar; Bruce A Perkins; Julio Rosenstock; David Z I Cherney
Journal:  Curr Diab Rep       Date:  2022-05-28       Impact factor: 4.810

Review 2.  Potential Use of SGLT-2 Inhibitors in Obstructive Sleep Apnea: A new treatment on the horizon.

Authors:  Cem Tanriover; Duygu Ucku; Merve Akyol; Enes Cevik; Asiye Kanbay; Vikas S Sridhar; David Z I Cherney; Mehmet Kanbay
Journal:  Sleep Breath       Date:  2022-04-04       Impact factor: 2.816

Review 3.  Cardiorenal Syndrome: The Role of Neural Connections Between the Heart and the Kidneys.

Authors:  Kaushik P Patel; Kenichi Katsurada; Hong Zheng
Journal:  Circ Res       Date:  2022-05-12       Impact factor: 23.213

4.  Markers of Kidney Injury, Inflammation, and Fibrosis Associated With Ertugliflozin in Patients With CKD and Diabetes.

Authors:  Hongyan Liu; Vikas S Sridhar; Leif Erik Lovblom; Yuliya Lytvyn; Dylan Burger; Kevin Burns; Davor Brinc; Patrick R Lawler; David Z I Cherney
Journal:  Kidney Int Rep       Date:  2021-06-05

5.  Mediators of ertugliflozin effects on heart failure and kidney outcomes among patients with type 2 diabetes mellitus.

Authors:  Matthew W Segar; Ahmed A Kolkailah; Robert Frederich; Annpey Pong; Christopher P Cannon; Francesco Cosentino; Samuel Dagogo-Jack; Darren K McGuire; Richard E Pratley; Chih-Chin Liu; Mario Maldonado; Jie Liu; Nilo B Cater; Ambarish Pandey; David Z I Cherney
Journal:  Diabetes Obes Metab       Date:  2022-06-15       Impact factor: 6.408

Review 6.  Effect of sodium-glucose cotransporter 2 inhibitors on hemoglobin and hematocrit levels in type 2 diabetes: a systematic review and meta-analysis.

Authors:  Mehmet Kanbay; Laura Tapoi; Carina Ureche; Cem Tanriover; Enes Cevik; Atalay Demiray; Baris Afsar; David Z I Cherney; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2021-07-17       Impact factor: 2.370
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.